- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07721246
Simulation-Based Patient Education to Adress Radiotherapy-Related Anxiety in Cancer Patients (ARAISE) (ARAISE)
Effects of a Simulation-Based Patient Education Intervention on Radiotherapy-Related Anxiety, Quality of Life, and Feasibility in Cancer Patients Receiving Radiotherapy: A Prospective Randomized Phase 2 Study (ARAISE)
For the majority of cancer patients, radiotherapy is a crucial component of their treatment process. However, many patients experience anxiety before or during radiotherapy. This anxiety may be related not only to the cancer diagnosis and its prognosis, but also to unfamiliar aspects of the treatment process, equipment, and treatment environment. General or non-specific feelings of anxiety may also become associated with the radiotherapy setting, even when patients are not able to identify a specific treatment-related concern. Uncertainty about what will happen during treatment sessions can further increase anxiety and may affect patients' overall well-being.
This study investigates whether an additional simulation-based patient education session before radiotherapy improves patients' understanding of their treatment and reduces radiotherapy-related state anxiety. Participants receiving radiotherapy will be assigned by chance to one of two groups. All participants will receive the usual patient education provided before radiotherapy. In addition, participants in one group will receive the simulation-based education session before the beginning of the treatment process. The study will compare changes in radiotherapy-related state anxiety and health-related quality of life between the two groups. It will also assess whether the additional education session is feasible, well accepted, and practical to provide as part of routine radiotherapy care.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Cancer remains one of the leading causes of death worldwide, and the global incidence of cancer is expected to continue rising over the coming decades. A substantial proportion of patients with cancer receives radiotherapy as part of their treatment. The expected rise in cancer incidence highlights the need to continuously enhance treatment pathways and to systematically address the needs of a growing heterogeneous patient population within routine care. In this context, the psychological burdens and supportive care needs experienced by patients during treatment have gained increasing attention.
Patients receiving radiotherapy may develop physical, psychological, existential, and social needs. Psychological distress and anxiety before and during treatment may persist throughout the course of illness and can negatively affect well-being, quality of life and the overall treatment experience. In addition, different professional groups involved in cancer care may have differing perceptions of patients' needs. Interdisciplinary and patient-centred assessments of these needs, followed by appropriately tailored information and educational interventions, may therefore be particularly relevant for patients receiving radiotherapy.
The state-trait anxiety model provides an established theoretical framework for understanding anxiety in clinical settings. State anxiety refers to a temporary emotional condition characterised by feelings of tension, apprehension, and increased autonomic arousal. Its intensity may vary depending on situational stressors. In the radiotherapy setting, potential triggers of state anxiety include unfamiliar radiotherapy equipment, the treatment environment, immobilization, being alone during radiation delivery, as well as misconceptions or uncertainty about the treatment process, its potential side effects, and its anticipated effects on health and daily life. Trait anxiety, in contrast, represents a more stable personal characteristic reflecting an individual tendency to perceive objectively low-risk situations as threatening and to respond with disproportionately high levels of anxiety. Both dimensions are relevant in the radiotherapy setting and the State-Trait Anxiety Inventory is an established instrument for the standardised assessment of both parameters.
Simulation-based patient-centred education may help patients prepare for radiotherapy by making the treatment environment and procedures more familiar before the beginning of the treatment process. Through a representation of the radiotherapy setting, enabled by a specific training software, patients understanding of the equipment, treatment process, and individual treatment situation can be supported. Previous studies suggest that virtual or simulation-based education may improve patient knowledge and reduce anxiety, although findings remain heterogeneous. Combining technological simulation with personal support from health care professionals may further enhance the educational benefit.
However, important evidence gaps remain. Previous designs have often been single-centred studies with small sample sizes and substantial variation in interventions, outcome measures, and assessment time points. Therefore, the sustained effectiveness, acceptability, and feasibility of simulation-based patient education in routine radiotherapy care require further investigation. In particular, it remains important to determine whether such interventions can meaningfully reduce radiotherapy-related anxiety, improve patients' understanding of treatment, and contribute to better quality of life.
Standard care commonly includes a medical consultation and routine information before treatment. However, standard education alone may not sufficiently address individual treatment-related fears and informational needs in all patients. Furthermore, radiotherapy-specific fears have not yet been comprehensively characterised from patient and professional perspectives, and structured approaches to support understanding and empathy for these concerns are limited in the education of health care professionals.
The ARAISE study follows a three-part research programme.
First, radiotherapy-related fears, concerns, and information needs among patients with advanced cancer will be systematically assessed through a multiprofessional needs assessment, including a Delphi survey to establish consensus. The findings will be used to inform the content and structure of the educational intervention.
Second, the use of a simulation-based radiotherapy programme will be evaluated in medical students. This work package will evaluate whether the simulation programme improves healthcare professionals' self-perceived understanding of radiotherapy from before to after programme use.
Third, the clinical component of the study will evaluate the effectiveness of a simulation-based patient education intervention in patients receiving radiotherapy for cancer. In this prospective, randomised, controlled study, participants will receive either standard patient education alone or standard patient education supplemented by a structured education session before radiotherapy begins. The clinical study aims to determine whether the additional intervention can reduce radiotherapy-related state anxiety and improve health-related quality of life compared with standard patient education alone. In addition, the study will assess the feasibility and acceptability of implementing the intervention in routine radiotherapy care. Overall, ARAISE aims to develop and evaluate a patient-centred educational approach that may improve patients' preparation for radiotherapy and support the integration of their individual informational and psychological needs into routine care.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Stephan-Peter Landgraff
- Telefonnummer: +49 172 8051175
- E-Mail: stephan.landgraff@medicalschool-berlin.de
Studieren Sie die Kontaktsicherung
- Name: Rami El Shafie, Prof. Dr. med
- Telefonnummer: +49 551 3964501
- E-Mail: rami.elshafie@med.uni-goettingen.de
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Age ≥18 years
- Histologically confirmed malignancy
- Planned first course of curative-intent fractionated radiotherapy
- Sufficient German language proficiency
- Written informed consent
Exclusion Criteria:
- Prior radiotherapy
- Inability to provide informed consent or complete study questionnaires
- Severe psychiatric disorder or cognitive impairment
- Visual impairment that precludes use of the simulation-based programme
- Pregnancy
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Kein Eingriff: Standard Patient Education
Participants will receive standard patient education before radiotherapy according to routine clinical practice.
Standard education includes the usual medical consultation and information about the planned radiotherapy treatment, treatment procedures, potential side effects, and practical aspects of care.
No additional simulation-based education session will be provided.
|
|
|
Experimental: Simulation-Based Patient Education
Participants will receive standard patient education before radiotherapy according to routine clinical practice.
In addition, they will receive a structured simulation-based patient education session before the start of radiotherapy.
|
A structured, simulation-based patient education session provided in addition to standard patient education before radiotherapy.
The session uses a software-based representation of the radiotherapy setting to familiarise participants with the treatment environment, radiotherapy equipment, treatment procedures, and their individual treatment situation.
Where appropriate, participants' own DICOM imaging data may be integrated with virtual patient models to support an individualised visualisation of the planned treatment.
The content particularly addresses radiotherapy-related fears, concerns, and information needs identified in the preceding multiprofessional needs assessment and Delphi survey.
The session is delivered with support from a member of the radiotherapy care team and does not alter the prescribed cancer treatment or routine radiotherapy care.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in state anxiety from baseline to first radiotherapy fraction
Zeitfenster: Baseline before randomization (T0) to first radiotherapy fraction (T2), approximately 1 to 3 weeks
|
Between-group difference in change in state anxiety from baseline to the first radiotherapy fraction, measured using the German version of the State-Trait Anxiety Inventory, State Anxiety scale (STAI-G Form X1).
The scale contains 20 items and total scores range from 20 to 80, with higher scores indicating greater state anxiety.
Baseline is assessed after the standard radiotherapy information consultation and before randomization (T0).
|
Baseline before randomization (T0) to first radiotherapy fraction (T2), approximately 1 to 3 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in state anxiety from baseline to fifth radiotherapy fraction
Zeitfenster: Baseline before randomization (T0) to fifth radiotherapy fraction (T3), approximately 1 to 3 weeks
|
Between-group difference in change in state anxiety measured using the German State-Trait Anxiety Inventory, State Anxiety scale (STAI-G Form X1).
Scores range from 20 to 80. Higher scores indicate greater state anxiety.
|
Baseline before randomization (T0) to fifth radiotherapy fraction (T3), approximately 1 to 3 weeks
|
|
Change in health-related quality of life
Zeitfenster: Baseline (T0) to first radiotherapy fraction (T2) and fifth radiotherapy fraction (T3), approximately 1 to 3 weeks
|
Between-group difference in change in global health status and functional scale scores measured with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30).
Higher scores indicate better global health status and functioning.
|
Baseline (T0) to first radiotherapy fraction (T2) and fifth radiotherapy fraction (T3), approximately 1 to 3 weeks
|
|
Feasibility and acceptability of simulation-based patient education
Zeitfenster: From enrollment to fifth radiotherapy fraction, approximately 3 - 4 weeks per participant
|
Recruitment rate, retention rate, protocol adherence, completeness of study data, and tolerability of the simulation-based patient education
|
From enrollment to fifth radiotherapy fraction, approximately 3 - 4 weeks per participant
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Rami El Shafie, Prof. Dr. med., Department of Radiation Oncology, University Medical Center Göttingen (UMCG)
- Studienleiter: Stephan-Peter Landgraff, Faculty of Health Sciences, Medical School Berlin (MSB)
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- ARAISE-RT-UMG-2026
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Simulation-Based Patient Education
-
ESRA ERTUĞRULNoch keine RekrutierungHerbst | Patientensicherheit | SimulationsausbildungTürkei (türkiye)
-
ESRA ERTUĞRULNoch keine RekrutierungHerbst | Patientensicherheit | SimulationsausbildungTürkei (türkiye)
-
Selçuk GörücüNoch keine RekrutierungPatientensicherheitTürkei (türkiye)
-
Hacettepe UniversityAbgeschlossenTyp 2 DiabetesTruthahn
-
University Hospital, MontpellierRekrutierung
-
University of BremenGerman Federal Ministry of Education and Research; Institute of Public Health... und andere MitarbeiterUnbekanntKrebsbedingte Müdigkeit
-
Lady Davis InstituteAbgeschlossenSklerodermie, systemischKanada
-
DERYA ESENKAYANoch keine RekrutierungChirurgische Ausbildung | Bildungstechnologie | OP-PflegeTürkei (türkiye)
-
Istanbul University - CerrahpasaAbgeschlossenKrankenschwester | Simulationsbasiertes Lernen | Standardisierter Patient | Selbstbewusstsein | Stoma -Pflegewissen und Fähigkeiten von KrankenschwesternTruthahn